MERIT
A feasibility study examining the use of Mechanical
Insufflation-Exsufflation to prevent extubation failure in adult
intensive care (The MERIT study)
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Grant Ref
|
Amount
|
Emma Swingwood
|
University Hospitals Bristol and Weston NHS Foundation Trust
|
01/09/2020 - 31/08/2023
|
NIHR HEE ICA Clinical Doctoral Research Fellowship
|
NIHR300504
|
£309,845.00
|
Background
There are about 230,000 adult intensive care (ITU) admissions
each year. Many of these patients require breathing support
from a machine and breathing tube. Most adults are
successfully removed from the breathing machine (extubation).
However 10-40% of patients are unable to breathe by themselves
once the tube has been removed and it needs to be put back in.
One of the main reasons for this is because the patients are
unable to cough well enough to clear mucus from their
airway. Having to have the breathing tube put back in leads to
worse outcomes for the patient, including prolonging their
length of hospital stay and increasing their risk of death.
To help with successful extubation, physiotherapists can use a
device to help patients cough and clear phlegm from their lungs.
The cough device works by blowing air into the patients lungs
followed by quickly sucking it out. This device can be used before
and after extubation. The cough device has only recently been used
in the ITU setting and there are no studies exploring patients
and/or healthcare professional's experiences of its use.
Aims
The aim of this research is to find out if it is possible to
carry out a large study to see whether using a cough device in
ITU can help patients be successfully removed from breathing
support.
Design and methods
There will be 4 stages:
1-Year 1. A detailed review of published work examining the role
of the cough device to help patients cough and clear
secretions. Interviews with ITU clinicians to explore their
thoughts about using the MI-E device with ITU patients.
2-Year 2. A small (feasibility) study of 50 patients to see if it
is possible to carry out a larger trial of the cough device.
The study will tell us whether it is possible to
recruit patients and whether they remain in the study. It will
also look at the safety of the cough device (most existing
safety data is from other hospital settings). Permission
(consent) for the study will need to be from family members as
patients will still be using the breathing machine when they
join the study. Patients will be asked for consent for ongoing
study participation once they are able.
3- Mid year 2 - mid year 3. Interviews with some of the patients
and clinicians involved in the feasibility study will seek
their experiences of using the cough device. Separate patient
consent will be sought for this. Physiotherapists will be
specifically approached for inclusion. Findings will be
discussed with groups of professionals from other hospitals to
inform future work.
4- Mid year 3. Completion of data analysis, write up and
dissemination.
PPI
Patients, carers and a patient support charity 'ICU Steps' have
been actively involved in the development of this application
through a PPI meeting, informal discussions and reading the
plain English summary. The chosen methods reflect these
discussions. ICU Steps have agreed to contact patients who
have been on ITU and have used a breathing machine to identify
at least two people to join the study advisory group. As the
study progresses, their views will continue to be sought.
Dissemination
There will be a study specific website and social media page.
Findings will be submitted to academic journals and
professional conferences. ICU Steps have agreed to help share
study findings at their regional meetings, and on their website.
The patient partners will help to ensure that the findings are
accessible to patients. Findings will also be shared with
healthcare professionals through newsletters,
website articles, presentations at relevant short courses and
conferences.